# Gemcitabine and S-1 for Advanced Biliary Tract Cancer

> **NCT02146703** · PHASE2 · COMPLETED · sponsor: **Hallym University Medical Center** · enrollment: 38 (actual)

## Conditions studied

- Biliary Tract Neoplasm

## Interventions

- **DRUG:** Gemcitabine, and S-1

## Key facts

- **NCT ID:** NCT02146703
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2010-11
- **Final completion:** 2013-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2014-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02146703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02146703, "Gemcitabine and S-1 for Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02146703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*